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Fig. 2. Drug dosage policy determined from FRL algorithm.
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tions are considered to show the growth of can cell population ver-
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The proposed model was simulated in Simulink environment,
where the fuzzy reinforcement learning controller is used. As shown
in Figure 1, two controllers evaluated the dosage of drugs. After
many iterations, fuzzy reinforcement learning presented a policy
used for therapy as shown in Figure 2. By using this policy, the trend
of drug dosage is shown in Figure 3. As illustrated in this graph, the
dosage of the first drug, imatinib and the second one, cytarabine is
decreased. It means the side effect of the drug considered in low
level. Nevertheless, the cell population number is decreeing in
Figure 4.
Conclusion: In this paper, a new free model based fuzzy rein-
forcement learning is introduced to meet the challenges of differ-
ent patient conditions. In this method, a controller system is
learned by some trial systematic therapies and finally make known
to an expert therapist machine which can set the drug dosage for
the proposed patient. Instead of a real patient, we used a mathe-
matical model which determined the population of cancer cell
for an special patient. By simulating the model in MATLAB-
SIMULINK environment and employing the revealed controller,
the achieved results show a reliably control by decreasing side
effects.
Keywords: Reinforcement learning, Fuzzy logic, Cancer cells
control, Mathematical model of cancer cellFig. 3. Drug dosage used for the proposed patient.
Fig. 4. Cancer population control versus time using FRL algorithm.
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Extended Abstract
Introduction: Breast cancer is the most frequent cancer and sec-
ond most common cause of cancer related death in women world-
wide. Although breast cancer is not a lethal cancer by self,
metastasis to distant organs is the main cause of breast cancer mortal-
ity and is associated with poor prognosis in breast cancer patients.
Spreading of tumor to auxiliary lymph node is one of the most impor-
tant factors predicting metastasis of tumor cells. Conventional thera-
peutic strategies include assessment of local lymph node involvement1 Atieh Eslahi, Mahdieh Daliri Ghouchan Atigh contributed equally to this
work.
36 Abstracts - 1st International Nastaran Cancer Symposium-2015 / Journal of Cellular Immunotherapy 1 (2015) 1e45by neoplastic cells. This helps to determining cancer stage, prognosis
and survival of patients. Therefore understanding of molecular mech-
anisms underlying metastasis of breast cancer has a vital importance
to prevention, early diagnosis and also improving of therapeutic strat-
egies. Recent growing evidence has supported the role of MicroRNAs
(miRNAs)as an important contributor to many human diseases
including breast cancer. In last decade studies have shown that
miRNA expression abnormalities are associated with tumor initiation,
development, progression, invasion, metastasis and response to ther-
apy. Therefore these molecules can be used as diagnostic, prognostic
and also predictive biomarkers. miRNAs are short non-coding RNAs
of 21e25 nucleotides that regulate gene expression post-transcrip-
tionally by binding to the 30 untranslated region (UTR) of target
mRNAs. Several studies have shown that miRNA expression profiling
can discriminate between normal breast tissue and breast cancer. Fur-
thermore evaluation of miRNAs profile can predict occurrence of
tumor metastasis. These studies suggest potential applications for cer-
tain miRNAs as biomarkers for breast cancer metastasis. MicroRNA-
124 is known as a tumor suppressor in several cancers including
breast cancer. Cellular models show that this microRNA is associated
with cell motility and invasion of tumor cells. However, there is no
information about microRNA-124 expression change during metasta-
sis process. Decoding of these changes may help better understanding
of process of metastatic cell invasion and also colonization in desti-
nation organ. In this experiment we compared the expression levels
of miRNA-124 in primary breast cancer tissues and metastatic
tumors.
Methods: Thirty fresh breast tumor tissue, and 30 tumor cell bear-
ing lymph node samples were gathered from pastor-no and Qaem
hospital of Mashhad, Iran. This study design was approved by local
ethics committee of Mashhad University of medical sciences and
all patients signed informed consent. None of patients recruited in
this study had undergone preoperative chemotherapy or radiotherapy.
Identity of tissue samples were confirmed by pathologist. Samples
were snapped frozen and stored in -80C until use. miRNAs from tis-
sue samples was extracted using Hybrid-R miRNA isolation Kit
(GeneAll, South korea) according to the manufacturer’s instructions.
Then, cDNA synthesis was carried out with miscript II RT kit (Qia-
gen, Germany) following the manufacturer’s protocol. Quantitative
RT-PCR was performed using sybergreen based miScript Precursor
Assays kit (Qiagen, Germany) and Prime Q-Master mix(Amplicon,
Denmark) in a Step One Real-time PCR system. Gene expression
changes were calculated using DDCt method. Independent T test
was performed to investigate difference in MIR-124 expression levels
between primary breast tumor samples and metastatic tissues. P<0.5
was defined as significant frequency difference between the two
groups.
Result: To investigate the expressional behavior of miR-124in
human breast cancer metastasis we compared miR-124 expression
level between breast cancer tumors and metastatic lymph nodes
from 60 patients. Quantitative real-time PCR analysis showed that
miR-124 expression increase in metastatic lymph nodes specimens
compared with primary breast tumor tissues (Figure 1).
Discussion: Breast cancer metastasis to distant organs is a very
complicated process that significantly reduces survival rate of breast
cancer patients. Fully characterization of metastasis process has a
vital importance to prevention of this process. Colonization of meta-
static cells into target tissues has a reverse order of biologic steps.
Mesenchymal to epithelial transition is one of the most important
steps in implantation of metastatic cells into target organs. Thisprocess includes the transition from motile, multipolar or spindle-
shaped mesenchymal cells to planar arrays of polarized epithelial
cells. Inhibiting this process can help to control tumor metastasis
as a therapeutic strategy in treatment of breast cancer. Several path-
ways contribute to MET process which can be candidate as thera-
peutic target. miR-124 is a tumor suppressor microRNA which
represses tumor growth, invasion and metastasis. miR-124 inhibites
breast cancer EMT via targeting Slug gene. Furthermore, this micro-
RNA targets TNF-a and inhibits EMT in prostate cancer cells. miR-
124 down regulation in breast cancer cell lines leads to increased
migration and invasion of cells. Furthermore reduction of miR-124
in primary breast tumor tissues is associated with increase of tumor
metastasis. Surprisingly, our results obtained by comparing of miR-
124 expression level in primary breast cancer cells and metastatic
cells showed increasing of miR-124 expression level in lymph
node metastasis samples versus primary tumors. In conclusion this
result suggests that miR-124 can be an important player in orches-
trating metastasis.
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Fig. 1. The expression of miR-124 was determined by quantitative real-time
PCR in60 metastatic breast cancer and tumor tissue.
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Extended Abstract
Introduction: Aflatoxins are important mycotoxins group which
are produced on agricultural products following growth of Asper-
gilli species especially A. parasiticus and A. flavus. Aflatoxin Bı
is the most toxic member of aflatoxin group, which is more frequent
on moldy foods and fodders. Fungal infection of food commodities
is more frequent worldwide, one these fungi is A. parasiticus the
producer of aflatoxin, which infect food products prior and post-
harvest, in storage and transportation. Pathogenicity depends on
immunity system condition of patients and fungal species. Viru-
lence of aflatoxin is governed by several gens, and there is no single
essential factor for development of fungi in patients. The aspergilli
infection types are increasing, which leads to considerable mortal-
ity. Due to its acute toxicity, oncogencity, mal effects on embryo
and mutagenic effects afaltoxin is most toxic for human health
among 400 mycotoxins. Aspergillus parasiticus is among the
